Cardiovascular drugs. II: Digoxin.
D000293:Adolescent; D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D001682:Biological Availability; D002315:Cardiopulmonary Bypass; D002648:Child; D002675:Child, Preschool; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000378:metabolism; D007408:Intestinal Absorption; D007700:Kinetics; D008431:Maternal-Fetal Exchange; D011247:Pregnancy
D000889:Anti-Arrhythmia Agents; D004077:Digoxin